Much research effort has been directed towards the modulation or prevention of metabolic syndrome diseases such as obesity, type 2 diabetes, and cardiovascular disease. The prevalence of obesity-related diabetes and cardiovascular disease is rapidly increasing worldwide, even in developing countries, 1, 2) and this is a growing health concern. 3) Studies of the effects of dietary and lifestyle factors on the prevalence and modulation of type 2 diabetes suggest that the majority of cases of type 2 diabetes may be ameliorated by the adoption of a healthier lifestyle. 4, 5) In addition to obesity caused by overeating and physical inactivity, a high-fat diet is particularly associated with insulin resistance, which is a major risk factor for the development of type 2 diabetes. 6) For example, it was recently reported that a low-fat, vegan and cereal diet was effective in the control of glycemic and lipid levels in type 2 diabetic patients. 7) It is well known that adipose tissue is not only a storage depot for fat, but also functions as an endocrine organ and has a key role in the control of endocrine signaling, glucose metabolism, inflammation, and energy homeostasis. 8) These functions of adipose tissue are mediated through a number of adipocytokines. [8] [9] [10] Of these adipocytokines, it has been established that adiponectin is a key adipocytokine in the regulation of metabolic syndrome 11, 12) and play pivotal roles in the improvement of insulin sensitivity and in the amelioration of glycemic control and type 2 diabetes. 8, 12, 13) In addition, epidemiological and experimental studies have shown that serum adiponectin levels are a highly sensitive marker in prediction of the development of type 2 diabetes, obesity, and cardiovascular disease. 14, 15) Dietary soy and cod proteins have been found to have beneficial effects on glycemic responses, insulin sensitivity, plasma adiponectin levels, and gene expression. 16, 17) These findings indicate the importance of an examination of the effects of diet on glycemic control and the plasma levels of adiponectin. However, the effect of dietary protein on glycemic responses and plasma adiponectin levels remains, in large part, unclear.
Millet is an important food crop in Asian and African countries. FAO reports have shown that millet ranks fifteenth among all crops in terms of calories produced for human consumption, and that, worldwide, millet production may be the primary calorie source for more than 500 million people. 18) In Japan, of the three millet types available, proso, foxtail, and Japanese millet, it is Japanese millet that accounts for the bulk of millet production. Japanese millet has traditionally been consumed directly in a mixed diet with rice, or as a rice substitute. Currently it is also used in the production of many food products, such as noodles, Japanese milletrye breads, porridge, and sweets. The prevalence of millet in the Japanese diet indicates the importance of investigation of the health-promoting effects of dietary millet. However, the health benefits of millet have been little studied with the exception of our previous studies.
We have reported that intake of a diet containing a proso-millet (Panicum miliaceum L.) protein concentrate, but not intake of a casein diet, clearly raises plasma levels of HDL cholesterol without causing an increase in low-density lipoprotein cholesterol levels in rats and mice. [19] [20] [21] We also found that the protein concentrate has a protective effect against hepatic injury induced by D-galactosamine in rats, 22) but the potential beneficial effect of Japanese millet on glycemic responses, or on the plasma levels of adiponectin and HDL cholesterol in type 2 diabetic animals, has yet to be investigated.
In the present study, we aimed to extend our research on the health benefits of millet by clarifying the beneficial effects of dietary Japanese-millet protein on glycemic responses, plasma levels of adiponectin, lipid and insulin, and on adiponectin gene expression in obese type 2 diabetic mice. The results of this study indicate that dietary millet induces a significant elevation in the plasma levels of adiponectin and HDL cholesterol, and decreases in those of glucose and triglycerides, which is accompanied by enhanced adiponectin gene expression. These findings should provide insight into the possibility of amelioration of type 2 diabetes by modulation of the diet. This is the first study to examine the health benefits of a diet based on Japanese millet for type 2 diabetes.
Materials and Methods
Materials. Pepsin (EC 3.4.23.1.) (1:10,000) from porcine gastric mucosa was purchased from Wako Pure Chemical Industries (Osaka, Japan). Alfa-amylase (Ractase SR-140) and glucoamylase (Magunax JW-203) were from Rakuto Kasei Co., Ltd. (Ohtsu, Shiga, Japan). All other laboratory chemicals were of the highest quality available and were purchased from Wako Pure Chemical Industries.
A traditional, non-glutinous type of Japanese millet (Echinochloa utilis, Ohwi et Yabuno, cv. Ninohe-Zairaihie), which is widely consumed in Japan, was used. The millet was grown in upland fields in Ninohe, Iwate, Japan in 2004 and harvested by a farmer, and the milled grain was used in the experiments. A typical composition of the milled grain was as follows (g/100 g): moisture, 12.8; protein, 11.1; lipid, 2.2; ash, 1.3; total dietary fiber, 0.8; non-fibrous carbohydrate by difference, 71.8.
Preparation of Japanese-millet protein concentrates. A Japanesemillet protein concentrate (JMP) was prepared according to a previously reported method 19) modified so that the protein content in the experimental diets was 20%. Briefly, starch was digested by the addition of a mixture of -amylase and glucoamylase, and incubation at 60 C for 24 h (pH 7.0) was done. Following removal of the soluble fraction, the remaining material was freeze-dried and defatted with n-hexane. A typical composition of the protein concentrate was as follows (g/100 g): moisture, 8.5; protein, 63.1; lipid, 1.3; ash, 2.1; total dietary fiber, 9.1 (anything that was insoluble), and non-fibrous carbohydrate by difference, 15.9. The protein concentrate did not contain soluble fiber.
The amino acid composition of the milled grain, and of the JMP, was determined in an amino acid analyzer (JLC-500, JEOL, Tokyo) ( Table 1) . Tryptophan content was analyzed by a photometric procedure after alkaline hydrolysis.
23) The contents of cystine and methionine were determined according to the method of Moore. 24) Compared to the amino acid content of casein, 25) the amount of alanine and cystine in the protein concentrate was higher, whereas that of lysine was much lower. These properties of the JMP were similar to those previously reported for proso millet. 19, 20, 22) Preparation of the starch and prolamin fractions of the Japanese millet. To test the effect of the carbohydrate component of Japanese millet on the plasma levels of glucose and adiponectin, a Japanesemillet starch preparation (JMS) was prepared. The protein component of the Japanese millet was removed by digestion of the protein with pepsin. First, water (4 liters) was added to 400 g of defatted Japanese millet flour. Then an amount of pepsin corresponding to 1% of the total protein in the mixture was added and the mixture was incubated at 37 C for 24 h at pH 2.0. After removal of the soluble (digested protein) fraction, the resulting material was freeze-dried. The content of resistant starch was determined with a resistant starch assay kit (Megazyme International Ireland, Wicklow, Ireland). The composition of the JMS (g/100 g) was as follows: moisture 0.21, protein 2.31, fat 1.4, ash 1.3, dietary fiber 1.8, resistant starch 1.2, and non-fibrous carbohydrate by difference 93.8.
To determine the effects of prolamin, the main protein component of Japanese millet, on plasma levels of glucose and adiponectin, the prolamin fraction was prepared from Japanese millet and fed to mice. Prolamin is the principal protein component of proso and foxtail millets, [26] [27] [28] and it has been found that it is also the main protein component of Japanese millet. 29) The prolamin fraction was separated from the Japanese millet according to a procedure reported previously. 28) In brief, the albumin and globulin fractions were extracted from the flour of defatted, milled Japanese millet with 0.5 M NaClwater at room temperature for 1 h and removed by centrifugation for 10 min. The prolamin fraction was then separated from the resulting insoluble material by incubation with 70% isopropyl alcohol at 60 C for 1 h, followed by centrifugation for 10 min. The supernatant, the prolamin containing fraction, was freeze-dried. The protein content was 39.3%.
Animals and diets.
Four separate experiments were performed using type 2 diabetic male KK-A y mice. The mice were obtained at 5 weeks of age, weighing 24-26 g, from Clea Japan (Tokyo) and maintained individually in stainless steel cages in an air-conditioned room at 22 AE 1 C at 55% humidity under a 12-h light/dark cycle (lights on from 06:00 to 18:00). The animals freely received diet and water in experiments 1-3. All animal experiments were performed according to the conditions established by the Animal Care and Use Committee of Iwate University.
In experiment 1, the effect of dietary JMP was examined in mice fed a diet containing a normal level of fat. After a 3-d period of adaptation, the mice were allocated to two groups of 6-7 animals each and fed a diet containing casein or JMP as a protein source for 3 weeks (Table 2 ). These diets contained 20% protein, and consisted of a modified AIN-93G diet.
30) The JMP diet was supplemented with L-lysine monohydrochloride and threonine to simulate the amino acid composition of casein. 25) Concentrations of fasting plasma glucose were monitored at weeks 0, 1, 2, and 3. Further, an oral glucose tolerance test (OGTT) was carried out on day 17 by administration of 1.5 g of glucose/kg of body weight of glucose with a stomach tube after a 16-h fast. Blood glucose was determined at 0, 30, 60, 90, and 120 min after the administration of glucose, and the area under the curve (AUC) was calculated. Animals were thereafter fasted for 6 h, and blood was collected from the abdominal vena cava in tubes containing EDTA under anesthesia with diethyl ether. The blood was quickly centrifuged at 3;550 g for 15 min at 4 C to obtain the plasma. After infusion with saline, the liver was removed. The kidneys and adipose tissues were also excised. All the samples were quickly frozen in liquid nitrogen and stored at À80 C until use. In experiment 2, the effect of feeding the JMP diet together with a diet of high fat content (JMPHF) was investigated. The animals were fed a casein diet for 3 d, and thereafter they were divided into two groups of 6-8 animals each. The mice were fed a high-fat diet containing casein (CHF) or JMP as a protein source for 3 weeks (Table 3) . They were thereafter subjected to the same procedures as in experiment 1.
In experiment 3, the effects of feeding JMS to mice on a high-fat diet on glycemic responses and plasma levels of adiponectin were investigated. The mice were fed a 20% casein diet for 3 d, and thereafter were divided into two groups of six animals each. One group was fed a high-fat diet containing JMS for 3 weeks, in which JMS was substituted for cornstarch (Table 4 ). This diet is referred to below as JMSHF. The control group was given a high-fat diet containing cornstarch ( Table 4 ). The protein content in these diets was reduced, and the starch content was increased as much as possible. The animals thereafter were subjected to the procedures described for experiment 1.
In experiment 4, the effects of dietary prolamin, obtained from Japanese millet, on the plasma levels of glucose, adiponectin, and insulin, and on the gene expression of adiponectin and TNF-in adipose tissue, were investigated. One group of mice was given 8 g of the CHF diet, shown in Table 3 , to which 120 mg of the prolamin fraction of millet was added every 2 d. The animals in the control group ingested 8 g of a CHF diet, referred to below as CHF8. The diet supplied was completely consumed within 2 d. After feeding for 14 d, the animals were subjected to the same procedures described for experiment 1.
Biochemical analysis of plasma and liver. The plasma concentrations of total cholesterol, HDL-cholesterol, triglyceride, and glucose were measured enzymatically with commercial kits (Total cholesterol E-Test Wako, HDL-cholesterol E-Test Wako, Triglyceride E-Test Wako, and Glucose CII-Test Wako, Wako Pure Chemical Industries, Osaka, Japan). Blood glucose levels at OGTT or during the experimental period of 3 weeks were analyzed with an Ascensia Autodisc Sensor-Dexter-Z II (Bayer Medical, Tokyo, Japan) using a small amount of blood obtained from the tail vein. The plasma insulin and adiponectin concentrations were measured with ELISA kits (the Levis mouse insulin kit, Shibayagi, Shibukawa, Gunma, Japan, and the mouse/rat adiponectin ELISA kit, Otsuka Pharmaceutical, Tokyo, Japan respectively). Liver lipids were extracted by the method of Folch et al., 31) and the cholesterol and triglyceride contents were measured with the above kits.
Quantitative analysis of gene expression. The adiponectin and TNF-mRNA levels in adipose tissue were analyzed by real-time PCR. Total RNA was extracted from perirenal adipose tissues using an RNeasy lipid tissue mini kit (Qiagen, Valencia, CA) according to the manufacturer's instructions. Total RNA samples (500 ng) were converted to cDNA by reverse transcription using the PrimeScriptÔ RT reagent kit (Takara Bio, Ohtsu, Japan). Real-time PCR was performed with the SYBR Ò Premix EX TaqÔ (Takara Bio) in a LightCycler (Roche Diagnostics, Mannheim, Germany) according to the manufacturer's instructions. Real-time PCR was carried out in duplicate for each sample. Gene expression was quantified relative to the expression of -actin. The relative concentration of DNA was analyzed by the fit point method using LightCycler software (ver. 3.5). The primer sequences used for PCR of adiponectin, TNF-, and -actin were as follows: adiponectin forward primer, 5 0 -CAG GCA Statistical analysis. Analysis of variance was done on the experimental data, and the differences between means were considered to be significant at p < 0:05 by Student's t test. These analyses were performed using InStat version 3.0 (GraphPad Software, San Diego, CA).
Results

Experiment 1 Effects of dietary JMP on blood components under normal dietary conditions
In this experiment, the effects of dietary JMP on blood levels of glucose, adiponectin, insulin, and lipids were compared to that of control dietary casein in mice fed a diet containing a normal level of fat. Food intake, body-weight gain, and the weight of adipose tissue did not differ between the two dietary groups, although the weight of the kidneys in the JMP diet group was lower than in the casein diet group (Table 5 ). Blood glucose levels at weeks 2 and 3 in the mice fed a JMP diet (251 AE 51 and 220 AE 50 mg/dl respectively) were significantly lower than those in the mice fed a casein diet (406 AE 84 and 312 AE 62 mg/dl, P < 0:01 and P < 0:05, respectively, Fig. 1A ). The consumption of a JMP diet also significantly reduced plasma glucose concentrations after feeding for 3 weeks as compared to those in mice fed a casein diet (379 AE 37 and 565 AE 72 mg/dl respectively, P < 0:001; Fig. 1B) . Intake of the JMP diet also significantly decreased blood glucose levels at 30, 45, 60, and 90 min as determined in an OGTT (P < 0:05, Fig. 1C ) and significantly induced a smaller AUC value as compared to the casein diet (P < 0:05, Fig. 1D ). Furthermore, although the plasma concentrations of total and HDL cholesterol, adiponectin, and insulin showed similar values for the two dietary groups (Table 5) , the triglyceride levels decreased significantly in the mice fed the JMP diet as compared to those fed the casein diet (P < 0:001, Table 5 ). The plasma triglyceride/HDL cholesterol ratios were calculated, since they are a useful surrogate marker of insulin resistance, as are fasting plasma insulin concentrations. 32, 33) This ratio was significantly lower in the mice fed the JMP diet (4:24 AE 1:14) than in those fed the casein diet (6:48 AE 0:76, P < 0:01, Table 5 ). Liver cholesterol and triglyceride contents were not altered by the different diets (Table 5) .
Experiment 2 Effects of intake of JMP on the levels of blood components under high-fat dietary conditions
The effect of feeding a JMP diet with a high fat content to mice was compared to that of feeding a highfat diet containing casein. Food consumption, bodyweight gain, and tissue weights did not differ between the two diet groups ( Table 6 ), except that liver weight in the JMPHF diet group was lower than in the CHF diet group (P < 0:05). Compared to the CHF diet group, the intake of a JMPHF diet significantly decreased fasting blood glucose levels throughout the experimental period of 3 weeks (P < 0:05, Fig. 2A ) and also significantly reduced plasma glucose concentrations after feeding for 3 weeks (478 AE 100 and 629 AE 21 mg/dl respectively, P < 0:05; Fig. 2B ). Significant changes in postprandial blood glucose responses, or in the AUC values obtained on OGTT, were not observed for the two diet groups (data not shown). However, the plasma concentrations of total and HDL cholesterol significantly increased (P < 0:05) in the mice on the JMPHF diet (189 AE 21 and 62:2 AE 9:5 mg/dl respectively) as compared to the mice on the CHF diet (152 AE 18 and 48:3 AE 7:9 mg/dl respectively, Fig. 3A and B ). In contrast, the level of triglyceride significantly decreased in the JMPHF group as compared to the CHF diet group (189 AE 57 and 256 AE 40 mg/dl respectively, P < 0:05; Fig. 3C ). The plasma triglyceride/HDL cholesterol ratio of the mice fed a JMPHF diet was significantly lower than that of those fed the CHF diet (3:11 AE 1:03 and 5:32 AE 0:51 respectively, P < 0:01; Fig. 4) . Moreover, the plasma Blood glucose levels in mice fed a high-fat diet containing casein or JMP over a 3-week period (A) and plasma glucose levels after feeding the diets for 3 weeks (B) were assayed as described in ''Materials and Methods.'' CHF indicates a casein diet with high fat and JMPHF a JMP diet with high fat, as detailed in ''Materials and Methods.'' The values are means AE SD for 6-8 animals. Asterisks indicate statistical differences between the JMPHF and CHF diet groups ( Ã P < 0:05). The plasma triglyceride/HDL cholesterol ratio was measured in mice fed a CHF or a JMPHF diet. The diets and feeding procedures are as described in Fig. 2 and detailed in ''Materials and Methods.'' The values are means AE SD for 6-8 animals. Asterisks indicate statistical differences between the JMPHF and CHF diet groups ( Ã P < 0:01).
adiponectin concentration in the mice fed the JMPHF diet was significantly higher than in the CHF diet group (24:2 AE 4:4 and 18:7 AE 2:5 mg/ml respectively, P < 0:05; Fig. 3D ). No significant difference in insulin concentration was observed between the two dietary groups (Table 6 ). There was also no significant difference in the content of liver cholesterol and triglyceride content between the two groups (Table 6 ).
Experiment 3 Effects of feeding of the starch fraction of Japanese millet under high-fat dietary conditions on blood components
The effect of feeding JMS to mice on a high-fat diet on the glycemic responses and plasma levels of adiponectin was investigated. Feeding of JMS as a starch source did not affect tissue weight or plasma concentrations of glucose or adiponectin as compared to the cornstarch-fed diet group (Table 7) . There were also no significant differences in blood glucose levels during the feeding of 3 weeks, and in the level of postprandial blood glucose concentrations or in the AUC values obtained on OGTT between the two diet groups (data not shown).
Experiment 4 Effects of feeding of the prolamin fraction of Japanese millet under high-fat dietary conditions on blood components and gene expression
The effects of dietary prolamin, obtained from Japanese millet, on the plasma levels of glucose, adiponectin, and insulin, and on the gene expression of adiponectin and TNF-in adipose tissue, were investigated. Food intake, body-weight gain, and the weight of adipose tissue of the mice fed a prolamin fraction from Japanese millet did not differ from those of the control CHF8 diet group (data not shown). However, ingestion of the prolamin fraction of millet decreased plasma glucose concentrations as compared to those of animals fed the CHF8 diet (178 AE 56 and 423 AE 87 mg/dl respectively, P < 0:0002; Fig. 5A ), and also significantly reduced insulin levels (2:50 AE 0:42 and 5:06 AE 2:26 ng/ml respectively, P < 0:01; Fig. 5B ). In contrast, the level of adiponectin did not show any significant difference between the two dietary groups (Fig. 5C) . Intake of the prolamin fraction significantly decreased plasma total cholesterol levels as compared to those of animals fed a CHF8 diet (113 AE 9 and 144 AE 23 mg/dl respectively, P < 0:05). There were, however, no significant differences in plasma HDL cholesterol, triglyceride, or triglyceride/HDL cholesterol ratio between the CHF8 and prolamin groups (data not shown).
Using real-time PCR for quantitative analysis of gene expression, we found that expression of adiponectin in perirenal adipose tissue was elevated by 42.6% in the mice that ingested the prolamin fraction of millet as compared to the CHF8 diet control group (142 AE 32 and 100 AE 19% respectively, P < 0:01; Fig. 6A ). In contrast, the expression of TNF-was decreased as compared to the CHF8 group (63:7 AE 34:8 and 100 AE 67% respectively, P < 0:1; Fig. 6B ).
Discussion
In the present study we found that the feeding of a JMP diet, under high-fat feeding conditions, to type 2 The plasma levels of glucose (A), insulin (B), and adiponectin (C) were measured in mice fed a CHF8 diet or a diet supplemented with the prolamin fraction of Japanese millet. One group of mice was given 8 g of the CHF diet as shown in Table 3 every 2 d, to which 120 mg of the prolamin fraction of Japanese millet was added. The control group of mice ingested 8 g of a CHF diet referred to as CHF8. The diet supplied was completely consumed over 2 days. For details, see ''Materials and Methods.'' The values are means AE SD for six animals. Asterisks indicate statistical differences between the prolamin and CHF8 diet groups ( Ã P < 0:05; ÃÃ P < 0:0002).
diabetic mice significantly increased the plasma levels of HDL cholesterol and adiponectin ( Fig. 3B and D) and significantly decreased blood glucose and triglyceride levels (Fig. 2, Fig. 3C ) as compared to the feeding of a CHF diet. The simultaneous increases in the levels of adiponectin and HDL cholesterol, and decreases in the levels of plasma glucose and triglyceride, are of particular interest. This is the first report that dietary protein can have beneficial effects on the plasma levels of adiponectin, HDL cholesterol, glucose, and triglyceride. It has been demonstrated that reduced plasma adiponectin levels induced by a high-fat diet can be partially increased by replenishment with recombinant adiponectin in KK-A y mice. 34) However, our findings show that feeding of a JMP diet can ameliorate plasma adiponectin levels (Fig. 3D) , suggesting that such a diet can play an important role in restoring the plasma level of adiponectin to physiological levels.
There have been other studies on the effects of dietary protein on plasma levels of adiponection and glucose. It has been reported that feeding of soy protein to rats increased both the plasma adiponectin concentration and the gene expression of adipose tissue, but did not affect plasma glucose or insulin concentrations.
16) The same research group also found that plasma glucose concentrations decreased, but that adiponectin concentrations were unaffected, under conditions of restricted food intake after feeding a soy protein diet with high fat to KK-A y mice. 35) Furthermore, it has been found that dietary cod and soy proteins decrease plasma glucose and insulin concentrations and improve glucose clearance and insulin sensitivity as compared with dietary casein. 36) A similar study indicated that insulin concentrations decrease due to the feeding of soy protein to rats. 37) A further study demonstrated that intake of whey protein reduced plasma insulin concentrations and increased insulin sensitivity as compared with intake of red meat, but did not affect plasma glucose concentrations. 38) These previous studies suggest that different dietary proteins differentially modulate metabolism, 38) and thus imply that a better choice of dietary protein is a more effective way to modulate glycemic control, insulin sensitivity, and levels of adiponectin and insulin. However, the effect of dietary protein on glycemic responses and on the plasma levels or gene expression of adiponectin are not fully established and are still controversial.
The elevation of adiponectin levels shown in this study in the JMP diet groups was accompanied by a significant decrease in glucose levels throughout the study period of 3 weeks ( Fig. 2A) as well as after 3 weeks of feeding (Fig. 2B) as compared with the levels in the casein diet groups under feeding conditions of high fat, which is inconsistent results for those under normal feeding conditions (Table 5 ). Thus our findings imply that JMP acts effectively to ameliorate adiponectin levels under more serious dietary conditions, suggesting differing effects between normal and high-fat feeding conditions. With regard to the decrease in glucose levels induced by dietary JMP, it has been well documented that dietary protein and amino acids can modulate glycemic control and insulin secretion. 17, 39) The effect of amino acids on endocrine responses is well established. For example, it has been found that leucine enhances insulin secretion, 39, 40) and dietary leucine has been proposed as a potential treatment for obesity and metabolic syndrome. 41) Recently it was reported that isoleucine administration lowers blood glucose in rats, 42) but it is unlikely that these amino acids are responsible for mediating the glycemic responses observed in this study, since the amounts of leucine and isoleucine in JMP were similar to those in casein (Table 1) . It is well established that increased adiponectin levels stimulate glucose utilization through activation of AMP-activated protein kinase in skeletal muscle and the liver. 10) Thus, a JMP diet should reduce glucose levels due to enhanced incorporation of glucose into peripheral tissues in response to JMP-induced elevated adiponectin levels.
There is evidence that a single administration of adiponectin to mice enhances hepatic insulin action, but that the effect of adiponectin on glucose levels is not associated with increased insulin levels. 43) Similarly, mice lacking adiponectin exhibit severe diet-induced insulin resistance. 44) Furthermore, adiponectin has been found to reverse insulin resistance associated with both lipoatrophy and obesity. 34) Hence it was claimed that adiponectin is a potent insulin enhancer linking adipose tissue and whole-body glucose metabolism. Other studies of humans with glucose intolerance and type 2 diabetes have indicated that higher plasma triglyceride levels are associated with lower HDL cholesterol levels. 45) To confirm the association of adiponectin with insulin resistance, we calculated the triglyceride/HDL cholesterol ratio in this study. This ratio is a highly predictive measure of insulin resistance, similar to fasting plasma insulin concentrations. 32, 33) It has been indicated that a ratio with a value greater than 3 indicates a high likelihood of insulin resistance, but that a value of less than 3 indicates increased insulin sensitivity. The ratios calculated for the mice fed a JMP diet, without or with high fat, were significantly lower than those for the casein and CHF diet groups (Table 5 , Fig. 4 ). In particular, the ratio calculated for mice fed the JMP diet containing high fat (3:11 AE 1:03) had a value very close to 3 (Fig. 4) . In this respect, it is recently found that serum levels of high-molecular weight adiponectin positively correlated with the levels of HDL cholesterol, and negatively correlated with the levels of triglyceride and with insulin sensitivity in type 2 diabetic patients with coronary artery disease. 46) Thus the data from the previous studies related above agree with the findings of this study. These findings strongly support the possibility that dietary JMP plays a role in the enhancement of insulin action through its effect on adiponectin, and suggest that JMP has the potential to ameliorate or attenuate insulin resistance in type 2 diabetes accompanied by hypertriglyceridemia.
In order to clarify the effective component of JMP that was responsible for the increase in plasma levels of adiponectin and HDL cholesterol and the decrease in glucose levels, we determined whether the starch or the protein component of JMP would induce these effects. When the starch fraction prepared from Japanese millet was fed to rats as a starch source (experiment 3), the intake of JMS did not influence glycemic responses or the plasma levels of adiponectin as compared to animals fed a cornstarch diet (Table 7) . Although it has been reported that resistant starch decreases postprandial blood glucose levels, 47) the content of resistant starch in JMS was small (1.2%). Thus it is unlikely that the changes in glucose levels observed in this study were influenced by the presence of resistant starch in JMS. The protein component of JMP that we tested was the prolamin fraction prepared from Japanese millet. Prolamin was used since it is the main protein in proso, foxtail, and Japanese millets. [26] [27] [28] [29] Our results show that prolamin clearly decreased plasma glucose and insulin concentrations as compared to those of animals fed the casein diet (Fig. 5A and B) . In additional experiments, we further found that ingestion of the prolamin fraction clearly upregulated the gene expression of adiponectin in adipose tissues as compared with that of animals fed the casein diet (Fig. 6A) and, in contrast, tended to downregulate the gene expression of TNF- (Fig. 6B) . However, the beneficial effects on gene expression were not accompanied by an increase in plasma adiponectin levels (Fig. 5C) , which is not consistent with results for soy protein.
16) The mechanism can not be identified by our limited experiments. Hence further studies to clarify effect of prolamin fraction on these gene expressions and plasma adiponectin levels are required. It is already known that increased gene expression of TNF-reduces adiponectin gene expression and plasma levels. 48) In summary, based on the results of these two critical experiments, we conclude that a protein alone, most probably prolamin, functions as an effective modulator of the plasma levels of glucose, adiponectin, and lipids.
The results obtained for Japanese millet in this study were different from our recent results obtained in studies using Korean foxtail 49) and proso millets. 50) Thus although elevation of adiponectin and HDL cholesterol concentrations was observed in mice fed with any of the three millets, the effects on glucose and insulin levels differed among the three. A reduction in glucose levels was found in mice fed a Korean proso-millet protein concentrate, but not in animals fed a concentrate of Korean foxtail millet. Furthermore, although insulin levels were unaffected by Japanese millet in the present study, they decreased in experiments using Korean foxtail and proso millets. These results suggest that the different effects of Japanese millet and Korean millets derive from differences in the physiological effectiveness of proteins in the different millet species.
The mechanisms by which dietary JMP affects HDL cholesterol and adiponectin levels are unclear. With regard to HDL cholesterol levels, it has been found that reduced lipoprotein lipase (LPL) activity contributes to lower HDL cholesterol levels in hypertriglyceridemia with insulin resistance. 51) In addition, it has been found that the main mechanism of production of plasma HDL cholesterol might be through the formation of HDL cholesterol particles from free cholesterol and phospholipids on the plasma membrane by ATP-binding cassette transporter A1. 52) Hence, in order to clarify the mechanism by which JMP affects HDL cholesterol levels, further studies of the effects of JMP on LPL activity and on the ATP-binding cassette transporter are required. LPL activity has also been reported to play a role in modulating adiponectin levels. 53) Furthermore, it is well established that treatment with thiazolidinediones, insulin-sensitizing agents, increases adiponectin levels through increased peroxisome proliferator-activated receptor-(PPAR) activity. 54, 55) Hence, future studies should address the question whether feeding of JMP modulates PPAR and LPL activity. On the other hand, it is known that the size of adipocytes influences the gene expression and secretions of adipocytokines such as adiponectin and TNF-. 10) But the sizes of adipocytes were not measured in this study. Thus, it is also important to determine how a JMP affects the sizes and differentiation of adipocytes. Epidemiological studies have reported the interesting observation that a diet low in glycemic load and high in fiber, from dietary cereal, increased adiponectin levels in diabetic men. 56) This study is valuable in its association of plasma adiponectin levels with diet, but it is unlikely that the fiber in JMP in the present study contributed to the increase in adiponectin levels, since the amount of fiber in the JMP diet was small.
In conclusion, this study clarifies the beneficial modulation of the levels of adiponectin, HDL cholesterol, glucose, and triglyceride due to dietary JMP. Considering the physiological significance of adiponectin and HDL cholesterol for type 2 diabetes, insulin resistance, and cardiovascular disease, the present findings suggest that dietary JMP has the potential to ameliorate these diseases. Further understanding of the mechanisms by which JMP exerts this beneficial modulation of glycemic response and the beneficial increase in plasma levels of adiponectin and HDL cholesterol may provide new insights into the preventive or protective effects of cereals on type 2 diabetes and atherosclerotic cardiovascular disease and into the use of cereals as a dietary therapy.
